Business
OTC Markets Group Welcomes Newly Verified OTCQB Companies – May 21
OTC Markets Group Welcomes Newly Verified OTCQB Companies – May 21.
About this update from Smartcool Systems Inc
[{"type":"text","content":"OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced the following companies are verified for trading on the OTCQB® Venture Marketplace:Advanced Environmental Recycling Technologies, Inc. (OTCQB: AERT) – Advanced Environmental Recycling Technologies, founded in 1988, develops and commercializes technologies to recycle waste polyethylene plastics and develops, manufactures, and markets value-added, green building products. The majority of its products are composite building materials that are a superior replacement for traditional wood or plastic products for exterior applications in building and remodeling homes and for certain other industrial or commercial building purposes. Its products are made primarily from approximately equal amounts of recycled polyethylene plastic and waste wood fiber, which have been cleaned, sized and reprocessed utilizing our patented and proprietary technologies. Its products have been extensively tested and are sold by leading national companies such as the Lowe's Companies, Inc. and Therma-Tru Corporation. Its products are primarily used in renovation and remodeling by consumers, homebuilders, and contractors as an exterior environmentally-responsible (\"treen\") building alternative for decking, railing, and trim products.AERT currently manufactures all of its composite products at extrusion facilities in Springdale, Arkansa, and it operates a plastic recycling, blending and storage facility in Lowell, Arkansas, where we also lease warehouses and land for inventory storage. It also operates a plastic recycling, cleaning, and reformulation facility at Watts, Oklahoma. Aethlon Medical, Inc. (OTCQB: AEMD) – The Aethlon Medical mission is to create innovative devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. The Aethlon ADAPT system is an expansive technology platform that converges affinity drug agents and plasma membrane technology to create therapeutic filtration devices that selectively target the removal of harmful particles from the entire circulatory system. The company’s lead therapeutic candidate is the Aethlon Hemopurifier, a device with broad-spectrum capabilities against viral pathogens and immunosup...